In this study, we explored the anti-AD activity of IFY in L-glutamate (L-Glu)-induced HT22 apoptotic cells, Aβ1-42-induced U251 apoptotic cells and the APPswe/PSEN1dE9 transgenic (APP/PS1) model. This evidence concerns the gene APP and Alzheimer disease.